FDA approves expanded indication for AstraZeneca's blood thinner
September 03, 2015 at 17:20 PM EDT
Sept 3 (Reuters) - AstraZeneca Plc said the U.S. Food and Drug Administration had approved a new dose of its blood thinner, Brilinta, for patients with a history of heart attack beyond the first year.
